This new intramural component will join the existing NIBIB Intramural Research Program, which includes the PET Radiochemistry Research Laboratory responsible for conducting research and training in the development and application of novel radiochemical probes for biomedical imaging, and the joint Laboratory for the Assessment of Medical Imaging Systems at the FDA.

The National Institute of Biomedical Imaging and Bioengineering (NIBIB), a component of the National Institutes of Health, U.S. Department of Health and Human Services, is dedicated to improving human health through the integration of the physical and biological sciences. The research agenda of the NIBIB will dramatically advance the Nation's health by improving the detection, management, understanding, and ultimately, the prevention of disease. Additional information and publications are available at www.nibib.nih.gov.


The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

Back to HCB News

More Industry Headlines